Plasma Circulating Deoxyribonucelic Acid (DNA) as a Response Marker
NCT00318604 · Status: UNKNOWN · Type: OBSERVATIONAL
Last updated 2006-05-12
Summary
This study investigates whether the amount of circulating plasma DNA can be used as a response marker for anti-cancer treatment in treating gross tumors.
Conditions
- Head and Neck Cancer
- Esophageal Cancer
Sponsors & Collaborators
-
Far Eastern Memorial Hospital
lead OTHER
Principal Investigators
-
LeJung Wu, MD, DPhil · Far Eastern Memorial Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
DNA Tests in Detecting Disseminated Disease in Tumor, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma
NCT01419509 ·Status: COMPLETED
-
Detection of Tumor DNA in Blood Samples From Cancer Patients
NCT02288754 ·Status: UNKNOWN
-
Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence
NCT03108885 ·Status: TERMINATED
-
Validation of DNA Methylation Biomarkers for Oral Cancer Detection
NCT02648789 ·Status: COMPLETED
-
Clinical Utility of Circulating Tumor DNA in Gastro-Esophageal Cancer
NCT04576858 ·Status: UNKNOWN
-
DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer
NCT00898664 ·Status: COMPLETED
-
ctDNA in Patients With Thyroid Nodules
NCT02778412 ·Status: TERMINATED
-
ctDNA as a Biomarker for Treatment Response in HNSCC
NCT03540563 ·Status: COMPLETED ·Phase: NA
-
Biomarkers in Patients With Head and Neck Cancer
NCT01466257 ·Status: COMPLETED
-
Validation of DNA Methylation Biomarkers for Oral Cancer Detection
NCT01945697 ·Status: COMPLETED
-
Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients
NCT00213798 ·Status: COMPLETED ·Phase: NA
-
Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic Disease
NCT02612350 ·Status: COMPLETED
-
Circulating Tumor DNA as a Prognostic Marker in Patients With Pancreatic Cancer
NCT03214991 ·Status: UNKNOWN
-
DNA Biomarkers in Tissue Samples From Patients With Osteosarcoma
NCT01190943 ·Status: COMPLETED
-
Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma
NCT04490564 ·Status: COMPLETED
-
Validation of DNA Methylation Biomarkers for Oral Cancer Detection-Follow up Study
NCT02902406 ·Status: UNKNOWN
-
DNA Analysis in Influencing Response to Rituximab in Samples From Patients With Follicular Lymphoma Treated on ECOG-E4402
NCT01406782 ·Status: COMPLETED
-
Molecular Genetics Study of Nasopharyngeal Carcinoma: Characterization of NCP Susceptibility Gene(s)
NCT00341146 ·Status: COMPLETED
-
Molecular and Genomic Profiling of Head and Neck Tumors
NCT00200486 ·Status: RECRUITING
-
Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic Osteosarcoma
NCT01062438 ·Status: COMPLETED
-
Liquid Biopsy in Head and Neck Cancer
NCT03926468 ·Status: UNKNOWN
-
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
NCT00242723 ·Status: RECRUITING
-
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
NCT04354064 ·Status: RECRUITING
-
Circulating Tumor DNA Exposure in Peripheral Blood
NCT03517332 ·Status: UNKNOWN
-
Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer
NCT03892096 ·Status: COMPLETED